Trending News Today: Phase 3 Study Will Evaluate Efficacy of Investigational HIV Vaccine
Top news of the day from across the health care landscape.
A new phase 3 study will evaluate whether an investigational HIV vaccine regimen is effective against different strains of the virus found across the globe, The American Journal of Managed Care reported. According to the article, the HPX2003/HVTN (Mosaico) trial will be launched by Janssen in collaboration with the National Institutes of Health and the HIV Vaccine Trials Network. The trial will look at various HIV strains among 3800 men who have sex with men and transgender individuals aged between 18 and 60 years, the article reported.
A report released by the World Health Organization (WHO) and the UNCIEF children’s fund showed that more than 1 in 10 children missed out last year on vaccines against life-saving diseases, Reuters reported. According to the article, WHO and UNICEF reported that since 2010, vaccination coverage with 3 doses of diphtheria, tetanus, and pertussis vaccine and 1 dose of measles vaccine has stalled at approximately 86%. Vaccination levels were most stagnant in poor countries or areas of conflict, the article reported.
A recent study showed that a healthy lifestyle may reduce the genetic risk of developing Alzheimer disease or other forms of dementia, The Associated Press reported. According to the article, the researchers used the UK Biobank to study approximately 200,000 individuals aged 60 years or older with no signs or symptoms of dementia at the start. Overall, the study demonstrated that individuals with a high genetic risk and poor health habits were approximately 3 times more likely to develop dementia compared with those who have a low genetic risk and good habits. A good diet, adequate exercise, limiting alcohol, and not smoking made dementia less likely, the article reported.